Related by context. All words. (Click for frequent words.) 74 GBA mutations 67 neurological abnormalities 67 hereditary predisposition 67 sCJD 67 ataxias 66 underlying pathophysiology 66 Genetic variants 65 familial clustering 65 MGUS 65 sporadic ALS 65 autosomal dominant inheritance 65 monoclonal gammopathy 64 susceptibility gene 64 familial pancreatic cancer 64 APOE genotype 64 progressive neurodegenerative disorder 64 biochemical abnormalities 64 chronic hepatitis cirrhosis 64 ADPKD 64 inherited predisposition 64 elevated triglyceride levels 64 familial ALS 64 basal cell nevus syndrome 64 Genetic predisposition 63 fronto temporal dementia 63 progressive neurodegenerative 63 MYCN amplification 63 Li Fraumeni syndrome 63 PTEN mutations 63 susceptibility locus 63 motor neuron degeneration 63 paraneoplastic 63 motor neuron diseases 63 predisposing factors 63 Chronic pancreatitis 63 multifactorial disease 63 CSF biomarkers 63 genetic polymorphisms 63 predisposing factor 62 EBV infection 62 mtDNA mutations 62 multisystem disease 62 missense mutations 62 APOE ε4 62 metabolic abnormality 62 neurodegenerative disorder 62 JAK mutations 62 inherited mutations 62 AAT deficiency 62 etiologic 62 germline mutations 62 nonmelanoma skin cancers 62 narcolepsy cataplexy 62 amyloid pathology 62 mitochondrial mutations 62 arterial calcification 62 monogenic 62 idiopathic PAH 61 chromosomal alterations 61 atypical parkinsonism 61 olfactory dysfunction 61 Parkinsonian Syndromes 61 polymorphic ventricular tachycardia 61 euthymic patients 61 susceptibility genes 61 modifier genes 61 astrocytomas 61 untreated celiac disease 61 neuro developmental disorder 61 leptin deficiency 61 induced cardiomyopathy 61 chronicity 61 spontaneous mutations 61 Brugada syndrome 61 dominantly inherited 61 autosomal dominant polycystic kidney 61 ApoE gene 61 multi infarct dementia 61 pathological hallmark 61 neurological disorder affecting 61 TGFBR1 * 6A 61 G#S mutation 61 brain lesions 61 thyrotropin levels 61 Hashimoto thyroiditis 61 TP# mutation 61 APOE e4 61 susceptibility loci 61 nonhereditary 61 familial adenomatous polyposis 61 parkinsonism 61 neuronal dysfunction 61 genetic variants associated 61 Alzheimer Disease AD 61 nondemented 61 pilocytic astrocytomas 61 molecular abnormalities 60 mitochondrial disorders 60 APOE4 60 proband 60 genetic polymorphism 60 neurocognitive impairment 60 incurable neurodegenerative disease 60 autosomal dominant disorder 60 genetic loci 60 LQTS 60 synaptic function 60 metabolic abnormalities 60 chromosomal anomaly 60 abnormal proteins 60 multi factorial disease 60 autonomic dysfunction 60 de novo mutations 60 genes predisposing 60 clinically detectable 60 alpha synuclein protein 60 HbF 60 mitochondrial dysfunction 60 IgA deficiency 60 chromosomal rearrangement 60 myopathies 60 subclinical atherosclerosis 60 aneuploidies 60 causative genes 60 genetic syndromes 60 obstructive coronary artery 60 microvascular disease 60 androgen deficiency 60 Sjögren syndrome 60 herpesviruses 60 penetrance 60 comorbid psychiatric 60 IPAH 60 KIBRA 60 neuropsychological deficits 60 G6PD deficiency 60 MYH9 gene 60 myeloproliferative neoplasms 60 LRRK2 mutation 60 inherited genetic mutations 60 pathophysiologic 60 parkinsonian 60 familial aggregation 60 idiopathic pulmonary arterial hypertension 60 idiopathic pulmonary 60 FTLD 60 anatomical abnormalities 60 comorbid depression 60 Leydig cell 60 shorter telomeres 59 Prostatitis 59 presymptomatic 59 neurologic disorders 59 HLA DRB1 59 neurologic disorder 59 developmental abnormalities 59 PTPN# 59 recessive genetic 59 demyelinating diseases 59 pathophysiological mechanisms 59 unprovoked seizures 59 mGluR2 NAM 59 retinal vascular 59 latent celiac disease 59 highly heritable 59 Eisenmenger syndrome 59 DNA methylation patterns 59 M. catarrhalis 59 LVNC 59 HIV HCV coinfected 59 p# activation 59 EoE 59 alpha thalassemia 59 SOD1 mutations 59 bicuspid aortic valves 59 Parkinson Disease PD 59 HSV1 59 etiologic agent 59 renal scarring 59 chromosomal anomalies 59 Hurthle cell 59 gastrointestinal dysfunction 59 aetiological 59 neuroinflammation 59 POAG 59 diabetic kidney 59 Raynaud syndrome 59 #q#.# [001] 59 comorbid anxiety 59 neurocognitive disorder 59 genetic determinants 59 Squamous 59 C. trachomatis 59 neuropsychiatric diseases 59 LRRK2 gene 59 airway remodeling 59 amyloid deposition 59 cranial irradiation 59 neuropathologic 59 comorbid disorders 59 PARP inhibition 59 tau pathology 59 neurocognitive deficits 59 prognostic marker 59 carotid plaques 59 pathophysiologic mechanism 59 alpha1 antitrypsin AAT deficiency 59 remyelination 59 thiopurine 59 CP CPPS 59 inherited neurological disorder 59 Hp2 2 59 neurosensory 59 neuro degenerative diseases 59 familial polyposis 59 Huntingtons disease 58 gene locus 58 breast endometrial 58 sonographic diagnosis 58 genetically inherited 58 susceptibility alleles 58 psychosocial variables 58 elevated CRP 58 gene polymorphism 58 pathogenetic mechanisms 58 atopic disorders 58 pernicious anemia 58 herpes simplex encephalitis 58 progranulin mutations 58 causative gene 58 genetic susceptibility 58 hereditary hemochromatosis 58 HIVAN 58 neuropsychological impairments 58 degenerative neurological diseases 58 immunodeficient 58 molecular underpinnings 58 intestinal polyps 58 HNPCC 58 DQB1 * 58 Jill Stautner 58 myeloproliferative neoplasms MPNs 58 CHD7 58 neurodevelopmental disorder 58 distinct subtypes 58 mutated K ras 58 gene variants 58 hepatocellular carcinomas 58 cardioembolic stroke 58 HLA B# 58 nonalcoholic steatohepatitis 58 IDH mutations 58 gene polymorphisms 58 Genetic mutation 58 frontotemporal dementia 58 abnormalities 58 testicular tumors 58 SSc 58 retinal dysfunction 58 phenotypic expression 58 choroidal neovascularization 58 genetic locus 58 C. pneumoniae 58 oxysterols 58 leukodystrophies 58 demyelinating 58 HGPS 58 Cognitive impairment 58 familial hypercholesterolemia FH 58 epithelial barrier 58 hydrops 58 pathogenic mechanisms 58 autoimmune pancreatitis 58 immunodeficiencies 58 G#S [002] 58 subclinical hyperthyroidism 58 Aß 58 biologic pathways 58 nonalcoholic steatohepatitis NASH 58 metaplasia 58 Neurofibromatosis type 58 coinfection 58 microbleeds 58 K ras mutations 58 seropositivity 58 underdiagnosis 58 mitochondrial DNA mutations 58 Diabetic neuropathy 58 thyroid dysfunction 58 CDH1 58 endocrine therapies 58 endophenotypes 58 Wernicke Korsakoff syndrome 58 chromosomal disorders 58 subclinical hypothyroidism 58 systemic amyloidosis 58 choroidal vasculopathy 58 spongiform encephalopathies 58 MYH9 58 chorioamnionitis 58 Chlamydia pneumoniae 58 hereditary degenerative 58 subclinical 58 amyloid beta plaques 58 clinically heterogeneous 58 enterocolitis 58 ATTR CM 58 neuro degenerative disorders 58 hypercalciuria 58 congenital deficiency 58 Chronic lymphocytic leukemia 58 decompensated cirrhosis 58 acute lymphoid leukemia 58 lipodystrophy syndrome 58 thyroid abnormalities 58 dopaminergic therapy 58 Dilated cardiomyopathy 58 stratifying patients 58 Vitamin B# deficiency 58 interstitial nephritis 58 malignant lymphomas 58 hyperinsulinism 58 underlying molecular mechanisms 58 airway hyperresponsiveness 58 MELAS 58 gene APOE 58 amnestic MCI 58 disabling neurological 58 TTR amyloidosis 58 nerve degeneration 58 SCN5A 58 familial hypercholesterolemia 58 chromosomal instability 58 pathogenic mutations 58 Excessive daytime sleepiness 58 GIST tumors 57 neovascularisation 57 squamous cell lung cancer 57 ADAM# 57 Klinefelter syndrome 57 glial tumors 57 genomic biomarker 57 colonic mucosa 57 SHANK3 57 diabetes mellitus DM 57 PTEN gene 57 methylation markers 57 leukoencephalopathy 57 ADAMTS# 57 5q 57 pre malignant lesions 57 neuropsychiatric disorder 57 neuritic 57 Genetic variations 57 BMPR2 57 epigenetic changes 57 shorter telomere length 57 phenotypic variation 57 impaired cognition 57 temporal arteritis 57 myeloproliferative diseases 57 Li Fraumeni 57 transgenic mouse models 57 orchitis 57 artery stenosis 57 Henoch purpura 57 carcinoid 57 alpha1 antitrypsin deficiency 57 proliferative diabetic retinopathy 57 chronic obstructive airway 57 cryptogenic 57 prostate carcinogenesis 57 genomic variants 57 autoimmune thyroid 57 focal segmental glomerulosclerosis FSGS 57 #q# deletion 57 neuro degenerative disease 57 PsA 57 Bardet Biedl Syndrome 57 enteroviral infection 57 INF2 57 Medullary thyroid cancer 57 Hereditary angioedema 57 clefting 57 ANCA associated 57 autoimmune thyroiditis 57 #q# [001] 57 SOD1 mutation 57 structural abnormalities 57 pharmacologic intervention 57 neuro degenerative disorder 57 postoperative delirium 57 progressive degenerative neurological 57 auditory neuropathy 57 CNTNAP2 57 biochemical imbalance 57 breast cancer metastasis 57 primary aldosteronism 57 TCF#L# gene 57 shortened telomeres 57 neurological manifestations 57 renal carcinoma 57 Hypertrophic cardiomyopathy 57 RET PTC rearrangements 57 interstitial fibrosis 57 autopsied brains 57 pancreatic endocrine 57 apolipoprotein E gene 57 debilitating autoimmune 57 myeloproliferative 57 WNK1 57 gene APOE4 57 metabolomic profiles 57 aMCI precursor 57 alexithymia 57 activated microglia 57 CC genotype 57 neurologic sequelae 57 de ath 57 GSTM1 gene 57 physiological abnormalities 57 fatal neuromuscular disorder 57 SGPT 57 juvenile idiopathic arthritis JIA 57 heritable diseases 57 neuroligins 57 psychiatric comorbidity 57 CALHM1 57 ectodermal dysplasia 57 neuro developmental disorders 57 mitochondrial abnormalities 57 etiologic factors 57 supratentorial 57 abnormal glucose metabolism 57 inflammatory bowel diseases 57 hepatitis B infection 57 immunocompetent 57 autosomal recessive disease 57 AUDs 57 Alpha synuclein 57 infantile hemangioma 57 Myotonic dystrophy 57 neoplastic 57 rheumatic disease 57 CMV infections 57 apoE4 57 immunodeficiency disorders 57 essential thrombocythemia 57 liver metastasis 57 hypercoagulable 57 hypovitaminosis D 57 NPHP 57 SLC#A# [002] 57 coagulation abnormalities 57 proliferative retinopathy 57 circadian genes 57 TPMT 57 JAK2 mutation 57 haemochromatosis 57 Multivariate analyzes 57 myelogenous leukemia 57 renal cell carcinomas 57 childhood leukemias 57 nodal metastasis 57 precancerous cervical 57 bile duct obstruction 57 p# mutations 57 Heavy menstrual bleeding 57 biomarker assay 57 relapsed ALL 57 SMN protein 57 low ptau levels 57 neurogenerative diseases 57 cognitive impairment 57 osteosarcomas 57 hyperparathyroidism 57 causal pathway 57 KRAS oncogene 57 HNSCC 57 dysgenesis 57 SNP rs# [001] 57 GSTM1 57 neurocognitive dysfunction 57 chromosome rearrangements 57 coronary calcification 57 OGG1 57 obstructive lung 57 pleiotropic effects 57 obesity insulin resistance 57 type2 diabetes 57 BRCA1 mutations 57 diagnose Alzheimer disease 57 degenerative disorders 57 nonischemic 57 causative mutation 57 TMEM#B 57 genetic heterogeneity 57 VCFS 57 prion infection 57 neurogenic 57 T1DM 57 viral etiology 57 M. pneumoniae 57 lysosomal storage diseases 57 precancerous condition 57 mGluR5 antagonist 57 debilitating neurodegenerative disorder 57 familial predisposition 57 cystic fibrosis muscular dystrophy 56 arteriosclerotic 56 proliferative disorders 56 testicular germ cell 56 neurological complications 56 urate levels 56 inherited retinal 56 prognostic biomarker 56 liver scarring 56 genomewide association studies 56 neuroblastomas 56 Epstein Barr virus EBV 56 inflammatory polyarthritis 56 GPC5 56 angiographically 56 potentially modifiable 56 periodontal infection 56 neurologic complications 56 varicella infection 56 ApoE4 gene 56 Lung transplantation 56 HLA DQ2 56 primary progressive aphasia 56 neuroblastoma tumors 56 malignant lymphoma 56 gastric carcinoma 56 amyloid plaque formation 56 antiphospholipid antibodies 56 Genetic variation 56 incurable neurological disorder 56 epithelial tissues 56 endocannabinoid signaling 56 epididymitis 56 neurologic symptoms 56 transient elastography 56 chemoresistant 56 polyglutamine diseases 56 serum markers 56 Clusterin 56 transgenic mouse model 56 PAOD 56 root caries 56 prenatally diagnosed 56 prostate cancer CaP 56 MSMB 56 genetic abnormality 56 somatic mutations 56 MTHFR 56 XMRV infection 56 aortic atherosclerosis 56 telomere shortening 56 myelomas 56 Neurodegenerative diseases 56 cardiac channelopathies 56 nephritis 56 infecting organism 56 SOD1 gene 56 pheochromocytoma 56 SE alleles 56 Brugada Syndrome 56 Nicotine dependence 56 BRCA2 gene mutation 56 neurological degeneration 56 microdeletion 56 β amyloid 56 microsatellite instability 56 carcinoids 56 antiphospholipid syndrome 56 hypermethylated 56 TOP2A 56 GG genotype 56 degenerative neurological condition 56 MECP2 gene 56 Helicobacter pylori infection 56 respiratory viral infections 56 pituitary tumors 56 heterozygotes 56 CAG repeats 56 CTEPH 56 spinocerebellar ataxia 56 ERK signaling 56 CFH gene 56 serous ovarian cancer 56 hemoglobinopathies 56 levodopa induced 56 diffuse gastric 56 inherited genetic mutation 56 repolarization 56 immunodeficiency diseases 56 underactive thyroid gland 56 malignant brain 56 Korsakoff 56 lung epithelium 56 ovarian hormones 56 retinitis pigmentosa RP 56 alzheimer disease 56 maternally transmitted 56 utero exposure 56 adrenal function 56 murine models 56 neoplasias 56 GSTT1 56 Lafora disease 56 MEF2A 56 myeloproliferative disorders 56 chromosome abnormality 56 microvascular dysfunction 56 hematologic disorders 56 hyperprolactinemia 56 Oxidative damage 56 ciliopathies 56 prostate adenocarcinoma 56 metastatic gastric 56 Magnesium deficiency 56 chromosome abnormalities 56 mosaicism 56 T2DM 56 PALB2 56 myocardial dysfunction 56 cerebral vascular disease 56 microdeletions 56 vascular cognitive impairment 56 normal karyotype 56 polypoid lesions 56 optic neuropathy NAION 56 colorectal neoplasia 56 Six3 56 bronchopulmonary dysplasia 56 Haptoglobin 56 BH4 deficiency 56 adenomatous polyps 56 autosomal recessive genetic 56 cardiac dysfunction 56 genomic deletions 56 genetic predisposition 56 poorer prognosis 56 MTHFD1L gene 56 neoplastic diseases 56 epigenetic alterations 56 Relapsing remitting MS 56 tumor histology 56 skeletal metastases 56 microscopic colitis 56 axonal damage 56 SRBD 56 myocardial fibrosis 56 unknown etiology 56 chromosome translocations 56 lymph node enlargement 56 prothrombotic 56 beta amyloid peptides 56 definitively diagnose 56 Legg Calvé Perthes disease 56 smoldering myeloma 56 abnormal lipids 56 atrophic gastritis 56 ovarian malignancy 56 amenorrhoea 56 aberrant methylation 56 FGFs 56 KCNH2 56 IGFBP2 56 prognostic significance 56 Mitochondrial dysfunction 56 ARVD 56 primary hyperparathyroidism 56 carotid atherosclerosis 56 cystic kidney 56 prognostic indicators 56 nephrolithiasis 56 synaptogenesis 56 WDR# 56 molecular biomarkers 56 GSTP1 56 lupus multiple sclerosis 56 gastric atrophy 56 Parkinsons Disease 56 molecularly defined 56 gene mutations 56 Cholangiocarcinoma 56 rheumatic disorders 56 hyperplastic 56 myotonic dystrophy 56 galanin 56 Fatty liver 56 unexplained mental retardation 56 Gorlin syndrome 56 amyloid deposits 56 macrovascular complications 56 impaired glucose metabolism 56 incidentalomas 56 primary immunodeficiency 56 Vascular dementia 56 mesotheliomas 56 mitochondrial toxicity 56 diabetic polyneuropathy 56 paraganglioma 55 progressive neurologic 55 neuro degenerative 55 Inflammatory diseases 55 Bardet Biedl syndrome 55 Genetic mutations 55 colorectal adenoma 55 lateral sclerosis ALS 55 endotoxemia 55 chromosomal translocations 55 Kupffer cells 55 Cowden syndrome 55 Pseudomonas aeruginosa infections 55 B7 H3 55 malignant neoplasm 55 rheumatologic 55 KRAS mutations 55 leukaemias 55 multiple sclerosis lupus 55 unmeasured factors 55 neuroprotective effects 55 biochemical markers 55 node metastases 55 serum biomarkers 55 Zollinger Ellison syndrome 55 pathogenetic 55 inflammatory bowel syndrome 55 progranulin 55 arthropathy 55 neuronal function 55 hippocampal function 55 immunopathology 55 causal variants 55 Alzheimer pathology 55 hypogonadotropic hypogonadism 55 autistic traits 55 genetic mutations 55 torsade de pointes 55 Becker muscular dystrophy 55 TRAF1 C5 55 non aspirin NSAIDs 55 T2D 55 dysregulation 55 idiopathic myelofibrosis 55 enterovirus infection 55 FMRP protein 55 bacterial prostatitis 55 TNF blocker therapy 55 microangiopathy 55 metabolic dysfunction 55 Parkinsonian 55 muscular dystrophies 55 Acidosis 55 allergic dermatitis 55 pathognomonic 55 neuron degeneration 55 Colon polyps 55 pancreatic adenocarcinoma 55 apoE 55 impaired insulin secretion 55 2D 4D ratio 55 ORMDL3 55 leukemias lymphomas 55 prostate cancer PCa 55 NNRTI resistance 55 SGS# 55 Singh Manoux 55 metabolic disturbances 55 cerebral atrophy 55 skeletal fluorosis 55 hypometabolism 55 cerebrospinal fluid CSF 55 Alzheimer disease pathology 55 debilitating neurological disorder 55 ALI ARDS 55 cirrhosis liver failure 55 neuroendocrine cancers 55 Lewy body 55 FGFR2 gene 55 filaggrin 55 GISTs 55 undiagnosed celiac disease 55 bladder carcinoma 55 VHL gene 55 chronic urticaria 55 Lenzenweger 55 carotid stenosis 55 nephrosis 55 genetic variations 55 cardiac insufficiency 55 GH deficiency 55 schizophreniform disorder 55 APOE allele 55 elevated homocysteine 55 polycystic kidneys 55 rheumatoid arthritis lupus 55 da mage 55 prefrontal regions 55 pathologic fractures 55 PNH patients 55 metastatic bladder 55 CFTR gene 55 epigenetic silencing 55 beta amyloid accumulation 55 facioscapulohumeral muscular dystrophy 55 muscle degeneration 55 NP CRNs 55 homocystinuria 55 autosomal dominant 55 alpha synuclein gene 55 perfusion abnormalities 55 APOE gene 55 pathophysiological 55 MSH2 55 hepatic liver 55 adrenalectomy 55 hypertension diabetes mellitus 55 serum PTH 55 urolithiasis 55 neuro protective 55 ventricular enlargement 55 airway responsiveness 55 muscular dystrophy cystic fibrosis 55 lichen planus 55 demyelination 55 uveal melanoma 55 pharmacologic treatments 55 osteochondrosis 55 SORL1 gene 55 microRNA expression 55 neuroregenerative 55 aminotransferase 55 vascular dysfunction 55 hypercoagulability 55 urate 55 progressively degenerative 55 cervical carcinoma 55 SORL1 55 bronchoalveolar 55 neurocognitive function 55 isolated systolic hypertension 55 levodopa therapy 55 familial hypercholesterolaemia FH 55 optica 55 genetic variant 55 hippocampal atrophy 55 adrenal hormones 55 Spinal muscular atrophy 55 hematopoietic cancers 55 Male pattern baldness 55 CHEK2 55 acetabular dysplasia 55 Graves ophthalmopathy 55 chromosomal aberrations 55 splice junctions 55 atherosclerotic coronary 55 vitamin B# deficiency 55 bowel polyps 55 homozygosity 55 differential gene expression 55 RAS blockers 55 acute lymphoblastic 55 allelic variants 55 ABCB1 55 gliosis 55 undiagnosed untreated 55 Beta thalassemia 55 Aortic stenosis 55 HER2 positive cancers 55 gene MECP2 55 axonal degeneration 55 isotypes 55 BRCA1 BRCA2 55 esophageal squamous cell carcinoma 55 Wischik 55 LHON 55 leukemia lymphomas 55 incurable degenerative 55 neurofibrillary 55 biochemical imbalances 55 androgen depletion 55 cerebral infarction 55 HER2 overexpression 55 MTHFR gene 55 vasculopathy 55 autism susceptibility genes 55 ALK mutations 55 Chronic Myeloid Leukaemia 55 LRP5 55 cardiac abnormalities 55 CHRNA5 gene 55 chromosomal regions 55 epigenetic modification 55 sporadic Creutzfeldt Jakob 55 carcinoid tumors 55 schizotypal traits 55 Francisella 55 NOD2 55 chromosome #q#.# [001] 55 Korsakoff syndrome 55 genetic underpinnings 55 VaD 55 adiponectin levels 55 cytogenetic abnormalities 55 C1 INH deficiency 55 congenital anomalies 55 pulmonary metastasis 55 dementing illness 55 asymptomatic carriers 55 functional polymorphism 55 lysosomal diseases 55 CYP#A# gene 55 BRCA2 gene 55 LRAT 55 cognitively intact 55 lymphomas leukemias 55 renal fibrosis 55 chromosomal deletions 55 diagnostic modality 55 dyskeratosis congenita 55 colonic polyps 55 premalignant lesion 55 oncogenic mutations 55 PON1 55 cerebral microbleeds 55 insoluble plaques 55 gene predisposing 55 germline mutation 55 nonseminoma 55 H. pylori infections 55 arterial thickening 55 eosinophilia 55 atypical hemolytic uremic syndrome 55 oligodendroglial progenitor cells 55 hereditary pancreatitis 55 precursor lesions 55 progressive degeneration 55 lysosomal storage disease 55 tumor suppressor protein 55 histocompatibility 55 missense mutation 55 breast cancer susceptibility genes 55 dementing 55 sortilin 55 #q#.# [002] 55 Idiopathic pulmonary fibrosis 55 Hutchinson Gilford progeria 55 AChE inhibitors 55 PCNSL 55 Prox1 55 cerebellar hypoplasia 55 Hurler syndrome 55 comorbid illnesses 55 bullous pemphigoid 55 related maculopathy 55 post thrombotic syndrome 55 cognitive deficits 55 Phenylketonuria PKU 55 Loeys Dietz syndrome 55 neovascular 55 genetic aberrations 55 Lewy bodies DLB 55 gastro esophageal reflux 55 Multivariate analysis 55 lymphocytic 55 premorbid 55 tumorigenicity 55 APOE e4 allele 55 apolipoprotein E APOE 55 myofascial pain syndrome 55 extramedullary 55 FXTAS 55 C1q 55 infarcts 55 protein misfolding diseases 55 Inflammatory bowel diseases 55 inherit predisposition 55 thromboembolic disease 55 mito 55 BRCA1 mutation carriers 55 Mitral regurgitation 55 Peutz Jeghers syndrome 55 endocrine abnormalities 55 EGFR mutation status 55 ALDH2 deficient 55 #p# [001] 55 atopic 55 chromosomal mutations 55 nongenetic 55 Sarcopenia 55 prenatal exposures 55 exotropia 54 methylation patterns 54 gynecologic malignancy 54 neuronal degeneration